An Introduction to Neuropsychiatry
Neuropsychiatry is a field of medicine that involves the management of emotional, cognitive or behavioural symptoms that occur in patients with neurological conditions. These include Parkinson’s disease, dementia, epilepsy, Huntington’s disease, multiple sclerosis schizophrenia, and following stroke and brain injury. These symptoms can be disabling and as clinically relevant as symptoms more typical of the disorder. Assessment tools and diagnostic criteria are available, but there is a lack of routine screening of these signs and symptoms in clinical practice. Various pharmacological and non-pharmacological interventions exist, but these are limited by a lack of clinical evidence of efficacy, and this remains an area of high unmet need.
Emerging Perspectives in the Management of Agitation in Alzheimer’s Disease and Patients with Dementia
touchREVIEWS in Neurology. 2022;18(1):7–13 DOI: https://doi.org/10.17925/USN.2022.18.1.7
While Alzheimer’s disease (AD), the most common cause of dementia, is perhaps best characterized by cognitive decline, more than 90% of patients with dementia exhibit behavioural and psychological symptoms of dementia.1 The Cache County Study on Memory in Aging describes six areas of neuropsychiatric behavioural abnormalities in patients with AD and other dementias, comprising aggression, apathy, […]
Raising the profile of cognitive impairment in the diagnosis and management of relapsing MS: Multidisciplinary perspectives
Watch leading specialists discuss the importance of addressing cognitive impairment in the diagnosis and management of relapsing MS.
- Evaluate key characteristics when diagnosing relapsing MS and demonstrate knowledge of the underlying pathophysiology
- Recall the current treatment landscape for relapsing MS with a focus on evidence-based clinical recommendations for oral DMTs to inform shared treatment decision-making
- Recognize the importance of monitoring cognitive dysfunction in patients with MS and guide management strategies as needed
Emerging Perspectives in the Diagnosis and Management of Depression and Psychosis in Parkinson’s Disease
touchREVIEWS in Neurology. 2021;17(2):97–103 DOI: https://doi.org/10.17925/USN.2021.17.2.97
Parkinson’s disease (PD) is a progressive, neurodegenerative movement disorder and the second most common neurodegenerative disorder in the United States.1 In 2020, approximately 930,000 people in the United States aged 45 years and older developed the disease, and this number is expected to rise to 1,238,000 by 2030.2 The typical age of onset is around 60 years, […]
A Tailored Cognitive Behavioural Therapy Intervention for Depression in People Newly Diagnosed with Multiple Sclerosis
touchREVIEWS in Neurology 2021;17(2):68–9 DOI: https://doi.org/10.17925/USN.2021.17.2.68
Multiple sclerosis (MS) is a chronic neurological disease that is associated with high rates of depression and anxiety,1 particularly in the early stages of diagnosis.2,3 A growing body of evidence suggests that cognitive behavioural therapy (CBT) is an effective treatment for depression in people with MS.4,5 However, there is a lack of tailored CBT interventions for patients who […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!